Noninvasive liver fibrosis scores are associated with increased heart failure risk, with FIB-4, NFS, and APRI showing ...

Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to ...

(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).

Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

Figure 1. Illustration of the measurement plane positions. Left, third intercostal spaces; middle, fourth intercostal spaces; and right, fifth intercostal spaces. The numbers on the electrode belt ...

Spirometry, a type of pulmonary function test (PFT), is a non-invasive procedure ... Intra-thoracic restriction includes diseases of the lung parenchyma, including fibrosis. Sarcoidosis (an ...

MA Illustration and Visual Media explores the creation and contextualisation of images at a time of unparalleled possibilities for engagement in visual culture. From October 2024, you can only apply ...

Liver fibrosis is scarring of the liver. It has many causes, including alcohol-induced damage, infections, and diseases that harm the liver. Inflammation and injury of the liver can lead to scarring, ...

The term “progressive pulmonary fibrosis” or “PPF” is generally used to describe progressive lung fibrosis in an individual with an interstitial lung disease (ILD) other than idiopathic ...